Literature DB >> 28697136

Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions.

Katherine E Poruk1, Vicente Valero, Jin He, Nita Ahuja, John L Cameron, Matthew J Weiss, Anne Marie Lennon, Michael Goggins, Laura D Wood, Christopher L Wolfgang.   

Abstract

OBJECTIVES: Circulating epithelial cells (CECs) are identified in the blood of patients with intraductal papillary mucinous neoplasms (IPMNs) despite the absence of malignancy. We assessed the blood of patients undergoing resection for IPMN or other benign pancreatic lesions for CECs.
METHODS: Peripheral blood was collected from 26 patients prior to pancreatic resection and filtered by the ISET (Isolation by Size of Epithelial Tumor Cells) method. Circulating epithelial cells were identified with antibodies to cytokeratin and Pdx1 (pancreas and duodenal homeobox protein 1), a pancreas marker.
RESULTS: Nineteen patients underwent resection of an IPMN without associated malignancy. Eleven patients (58%) had cytokeratin-positive CECs. Circulating epithelial cells were significantly more likely to be found in patients with IPMNs with high-grade dysplasia (P = 0.04). In addition, 10 of the 11 patients with cytokeratin-positive CECs also had separate populations of cytokeratin-positive, Pdx1-positive CECs, suggesting a pancreatic source. Dual-staining CECs were more frequently found in patients with high-grade dysplasia (P = 0.04). Patients with IPMNs were significantly more likely to have pan-cytokeratin CECs in the blood compared with those without IPMNs (P = 0.01).
CONCLUSIONS: Circulating epithelial cells staining with potential pancreas-specific markers have been found in patients with IPMNs, even without malignancy. Circulating epithelial cells may help to differentiate patients with high-grade IPMN from lower grades of dysplasia and other pancreatic cysts.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28697136     DOI: 10.1097/MPA.0000000000000869

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  10 in total

1.  Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer.

Authors:  Marcia Irene Canto; Tossapol Kerdsirichairat; Charles J Yeo; Ralph H Hruban; Eun Ji Shin; Jose Alejandro Almario; Amanda Blackford; Madeline Ford; Alison P Klein; Ammar A Javed; Anne Marie Lennon; Atif Zaheer; Ihab R Kamel; Elliot K Fishman; Richard Burkhart; Jin He; Martin Makary; Matthew J Weiss; Richard D Schulick; Michael G Goggins; Christopher L Wolfgang
Journal:  J Gastrointest Surg       Date:  2019-06-13       Impact factor: 3.452

Review 2.  Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).

Authors:  Joseph Carmicheal; Asish Patel; Vipin Dalal; Pranita Atri; Amaninder S Dhaliwal; Uwe A Wittel; Mokenge P Malafa; Geoffrey Talmon; Benjamin J Swanson; Shailender Singh; Maneesh Jain; Sukhwinder Kaur; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-30       Impact factor: 10.680

Review 3.  From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.

Authors:  Catherine G Fischer; Laura D Wood
Journal:  J Pathol       Date:  2018-12       Impact factor: 7.996

4.  Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.

Authors:  Alessandra Pulvirenti; Georgios A Margonis; Vicente Morales-Oyarvide; Caitlin A McIntyre; Sharon A Lawrence; Debra A Goldman; Mithat Gonen; Matthew J Weiss; Cristina R Ferrone; Jin He; Murray F Brennan; John L Cameron; Keith D Lillemoe; T Peter Kingham; Vinod Balachandran; Motaz Qadan; Michael I D'Angelica; William R Jarnagin; Christopher L Wolfgang; Carlos Fernández-Del Castillo; Peter J Allen
Journal:  Ann Surg       Date:  2021-12-01       Impact factor: 13.787

5.  Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target.

Authors:  Joseph W Franses; Julia Philipp; Pavlos Missios; Irun Bhan; Ann Liu; Chittampalli Yashaswini; Eric Tai; Huili Zhu; Matteo Ligorio; Benjamin Nicholson; Elizabeth M Tassoni; Niyati Desai; Anupriya S Kulkarni; Annamaria Szabolcs; Theodore S Hong; Andrew S Liss; Carlos Fernandez-Del Castillo; David P Ryan; Shyamala Maheswaran; Daniel A Haber; George Q Daley; David T Ting
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

Review 6.  Circulating Tumor Cells for the Management of Renal Cell Carcinoma.

Authors:  Lucile Broncy; Patrizia Paterlini-Bréchot
Journal:  Diagnostics (Basel)       Date:  2018-09-03

Review 7.  Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells.

Authors:  Dannel Yeo; Althea Bastian; Heidi Strauss; Payal Saxena; Peter Grimison; John E J Rasko
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

Review 8.  Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe.

Authors:  Valeria Tonini; Manuel Zanni
Journal:  World J Gastroenterol       Date:  2022-08-21       Impact factor: 5.374

9.  High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery.

Authors:  Etienne Buscail; Catherine Alix-Panabières; Pascaline Quincy; Thomas Cauvin; Alexandre Chauvet; Olivier Degrandi; Charline Caumont; Séverine Verdon; Isabelle Lamrissi; Isabelle Moranvillier; Camille Buscail; Marion Marty; Christophe Laurent; Véronique Vendrely; François Moreau-Gaudry; Aurélie Bedel; Sandrine Dabernat; Laurence Chiche
Journal:  Cancers (Basel)       Date:  2019-10-26       Impact factor: 6.639

10.  GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype.

Authors:  Tatsuo Hata; Masamichi Mizuma; Fuyuhiko Motoi; Yuko Omori; Masaharu Ishida; Kei Nakagawa; Hiroki Hayashi; Takanori Morikawa; Takashi Kamei; Toru Furukawa; Michiaki Unno
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.